Now Approved: U.S. FDA approves product to reduce the incidence of catheter-related bloodstream infections (CRBSIs) under special pathway for patients receiving hemodialysis.

Veröffentlichungen und Präsentationen

September 15, 2016

Möglichkeiten zur Verringerung von Bakteriämierisiken bei Verwendung von getunnelten zentralvenösen Dialysekathetern
Hollenbeck, M. et al., Nephro-News 2014 (6): 13-19

Tunneled Catheters with Taurolidine-Citrate-Heparin Lock Solution Significantly Improve the Inflammatory Profile of Hemodialysis Patients
Fontseré, N. et al., Antimicrob. Agents Chemother. 2014 (58): 4180-4184

Prevention of Hemodialysis Catheter-Related Bloodstream Infection Using an Antimicrobial Lock
Quarello, F. and Forneris, G., Blood Purif. 2002 (1): 87-92

Central Venous Catheters and Catheter Locks in Children With Cancer: A Prospective Randomized Trial of Taurolidine Versus Heparin
Handrup, M.M. Pediatr. Blood Cancer, 2013 (60): 1292-1298

Taurolidine lock is highly effective in preventing catheter-related bloodstream infections on patients on home parenteral nutrition: A heparin-controlled prospective trial
Bisseling, T.M. et al. Clinical Nutrition, 2010 (29): 464-468